Angiogenesis Inducing Agents
"Angiogenesis Inducing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS.
| Descriptor ID |
D043925
|
| MeSH Number(s) |
D27.505.696.377.077.077
|
| Concept/Terms |
Angiogenesis Inducing Agents- Angiogenesis Inducing Agents
- Agents, Angiogenesis Inducing
- Inducing Agents, Angiogenesis
- Angiogenesis Stimulating Agents
- Agents, Angiogenesis Stimulating
- Stimulating Agents, Angiogenesis
- Angiogenesis Stimulators
- Stimulators, Angiogenesis
- Angiogenesis Inducers
- Inducers, Angiogenesis
Angiogenesis Effect- Angiogenesis Effect
- Effect, Angiogenesis
- Angiogenesis Effects
- Effects, Angiogenesis
|
Below are MeSH descriptors whose meaning is more general than "Angiogenesis Inducing Agents".
Below are MeSH descriptors whose meaning is more specific than "Angiogenesis Inducing Agents".
This graph shows the total number of publications written about "Angiogenesis Inducing Agents" by people in this website by year, and whether "Angiogenesis Inducing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Angiogenesis Inducing Agents" by people in Profiles.
-
Johnson T, Zhao L, Manuel G, Taylor H, Liu D. Approaches to therapeutic angiogenesis for ischemic heart disease. J Mol Med (Berl). 2019 02; 97(2):141-151.
-
Cai Z, Dong L, Song C, Zhang Y, Zhu C, Zhang Y, Ling Q, Hoffmann PR, Li J, Huang Z, Li W. Methylseleninic Acid Provided at Nutritional Selenium Levels Inhibits Angiogenesis by Down-regulating Integrin ?3 Signaling. Sci Rep. 2017 08 25; 7(1):9445.
-
Guo S, Gonzalez-Perez RR. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer. PLoS One. 2011; 6(6):e21467.
-
Chougule MB, Patel AR, Jackson T, Singh M. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PLoS One. 2011 Mar 15; 6(3):e17733.
-
Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res. 2011 May; 6(3):215-25.
-
Vivas-Mejia P, Benito JM, Fernandez A, Han HD, Mangala L, Rodriguez-Aguayo C, Chavez-Reyes A, Lin YG, Carey MS, Nick AM, Stone RL, Kim HS, Claret FX, Bornmann W, Hennessy BT, Sanguino A, Peng Z, Sood AK, Lopez-Berestein G. c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer. Clin Cancer Res. 2010 Jan 01; 16(1):184-94.
-
Calhoun CC, Cardenes O, Ducksworth J, Le AD. Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature. J Oral Maxillofac Surg. 2009 Nov; 67(11):2516-20.
-
Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J. 2008 May 19; 7:83.
-
Tarzami ST, Singh JP. Pharmacological revascularisation in coronary and peripheral vascular disease. Expert Opin Investig Drugs. 2004 Oct; 13(10):1319-26.
-
Banerjee DK. Angiogenesis: characterization of a cellular model. P R Health Sci J. 1998 Dec; 17(4):327-33.